Related Experiment Video

Updated: Jun 23, 2026

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment

Shiny Mathewkutty1, Darren K McGuire

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Expert Review of Cardiovascular Therapy
|May 8, 2009
PubMed

Insights

Type 2 diabetes mellitus (DM) increases cardiovascular disease (CVD) risk. Improving antiplatelet therapies offers a promising strategy to reduce residual CVD risk in patients with DM.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (DM) prevalence is rising globally, leading to increased cardiovascular disease (CVD) complications.
  • Despite advancements in evidence-based therapies, a residual CVD risk persists in patients with DM.
  • Platelet function is significantly altered in DM, suggesting potential benefits from improved antiplatelet strategies.

Purpose of the Study:

  • To explore the potential of enhanced antiplatelet therapies in mitigating residual cardiovascular disease risk in patients with Type 2 diabetes mellitus.

Main Methods:

  • Review of ex vivo platelet function assessments in diabetic patients.
  • Analysis of clinical outcomes trials evaluating antiplatelet agents in high-risk populations.

Main Results:

  • Emerging data suggest that perturbations in platelet function associated with DM contribute to residual cardiovascular risk.
  • Clinical outcomes trials provide preliminary support for the efficacy of certain antiplatelet approaches in this cohort.

Conclusions:

  • Optimizing antiplatelet therapies represents a key opportunity for clinical advancement in managing cardiovascular risk in Type 2 diabetes mellitus.
  • Further research and development in antiplatelet strategies are warranted for this vulnerable patient population.

More Related Videos

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...